Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Skin Cancer01:30

Skin Cancer

3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
Pigmentation01:19

Pigmentation

2.2K
The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
2.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.3K
Cancer02:18

Cancer

47.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Study Protocol for a Randomized Clinical Trial Investigating the Effect of Reduced Bleomycin in Electrochemotherapy Treatment on Patients with Cutaneous Metastases (The BLESS Trial).

Bioelectricity·2026
Same author

A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial).

Journal of visualized experiments : JoVE·2026
Same author

Isotretinoin is not associated with elevated risk of pseudotumor cerebri: A Danish register-based cohort study.

Journal of the American Academy of Dermatology·2026
Same author

Ultrasound-Based Techniques for Visualization of Dermal Microvasculature: A Scoping Review.

Diagnostics (Basel, Switzerland)·2026
Same author

Incidence of lymphomas in a nationwide prospective cohort study of breast-implanted women.

Breast (Edinburgh, Scotland)·2026
Same author

Autologous Patch Healing vs Secondary Intent Healing after Mohs Micrographic Surgery: A Randomized Controlled Trial.

Acta dermato-venereologica·2026

相关实验视频

Updated: May 16, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.6K

[黑色素瘤] 这是什么?

Mette Mogensen1,2, Terese von Knorring1, Lisbet Rosenkrantz Hölmich2,3

  • 1Dermato-Venerologisk Afdeling, Københavns Universitetshospital - Bispebjerg og Frederiksberg Hospital.

Ugeskrift for laeger
|April 2, 2025
PubMed
概括

全球黑色素瘤的发病率正在上升,丹麦的病例翻了一番. 早期检测是关键,但改进的诊断工具和公众意识对于更好的黑色素瘤诊断和治疗至关重要.

更多相关视频

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.6K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.3K

相关实验视频

Last Updated: May 16, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.6K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

8.6K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.3K

科学领域:

  • 皮肤病学和公共卫生

背景情况:

  • 全球黑色素瘤发病率正在上升,在过去25年中,在丹麦观察到的显著增加.
  • 早期发现黑色素瘤至关重要,但在准确诊断早期黑色素瘤和非典型瘤方面面临挑战.

研究的目的:

  • 审查丹麦医疗保健系统内的黑色素瘤诊断过程.
  • 突出目前和新兴的黑色素瘤诊断工具.
  • 强调需要提高诊断准确度,以尽量减少不必要的切除.

主要方法:

  • 审查目前的文献和诊断实践在丹麦.
  • 讨论新兴技术,包括在黑色素瘤诊断中的人工智能 (AI).
  • 分析公共教育在黑色素瘤自我检测中的作用.

主要成果:

  • 目前的诊断方法在区分黑色素瘤和非典型瘤方面存在局限性.
  • 人工智能显示出潜力,但尚未超过经验丰富的皮肤科医生.
  • 公共教育仍然是一个关键的组成部分,因为许多黑色素瘤病例是自我检测.

结论:

  • 提高诊断准确度对于改善黑色素瘤患者的治疗结果至关重要.
  • 需要进一步研究和开发包括人工智能在内的诊断工具.
  • 关于子变化的持续公众宣传活动对于早期发现黑色素瘤至关重要.